Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration
06 sept. 2012 09h32 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., and CAMBRIDGE, UK, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small...
Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference
04 sept. 2012 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at September Investor Conferences
30 août 2012 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
20 août 2012 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Aug. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Reports 2012 Second Quarter Financial Results
30 juil. 2012 16h00 HE
|
Astex Pharmaceuticals, Inc.
Dacogen Royalty Revenue Increased 25% From Prior Year
$5.4 Million Earned on Phase I Trial Initiation of FGFR Kinase Inhibitor
Dacogen Receives Positive Regulatory Recommendation in the EU for...
Astex Pharmaceuticals to Announce 2012 Second Quarter Financial Results on July 30, 2012
24 juil. 2012 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia
20 juil. 2012 10h34 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Board Member Wins 2012 European Mediscience Award
10 juil. 2012 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients
22 juin 2012 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor
13 juin 2012 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...